Clear cell endocrine pancreatic tumor mimicking renal cell carcinoma: a distinctive neoplasm of von Hippel-Lindau disease.
The dominantly inherited von Hippel-Lindau disease is characterized by clear cell neoplasms in various organs including the kidney and pancreas. Determination of primary versus metastatic lesion in this setting can be a diagnostic dilemma. The authors present five cases of clear cell endocrine pancreatic tumor (EPT) closely mimicking renal cell carcinomas in five patients with a family history or histologic evidence of von Hippel-Lindau disease. In fact, two of these tumors were confused with metastatic renal cell carcinoma by fine-needle aspiration. All five tumors had a component of clear cells arranged in nests, cords, and tubules with central hemorrhage separated by thin-wall vessels resembling renal cell carcinoma. However, these tumors also exhibited cords and festoons and a gyriform pattern suggestive of an endocrine neoplasm, and expressed chromogranin and synaptophysin. Vascular invasion was identified in four tumors, one of which metastasized. The concurrent primary renal cell carcinomas and the multicentric microcystic adenomas found in three patients did not show reactivity for the neuroendocrine markers. Focal clear cell change was noted in only one of 29 endocrine pancreatic tumors arising in patients without von Hippel-Lindau disease. Eleven metastatic renal cell carcinomas in the pancreas did not show immunoreactivity with the endocrine markers. Clear cell EPTs closely mimicking renal cell carcinoma are distinctive neoplasms of von Hippel-Lindau disease. In contrast to clear cell EPT, metastatic renal cell carcinoma does not express neuroendocrine markers and lacks neurosecretory granules by electron microscopy. Von Hippel-Lindau disease should be strongly suspected in patients with renal cell carcinoma, clear cell EPT, and multifocal microcystic serous adenomas.
Hoang
M P
MP
Department of Pathology, The University of Texas Southwestern Medical Center, Dallas 75390-9073, USA.
Hruban
R H
RH
Albores-Saavedra
J
J
D018262:Adenocarcinoma, Clear Cell / Q000737:chemistry / Q000175:diagnosis* / Q000209:etiology; D000328:Adult; D014408:Biomarkers, Tumor / Q000032:analysis; D018273:Carcinoma, Islet Cell / Q000737:chemistry / Q000175:diagnosis* / Q000209:etiology; D002292:Carcinoma, Renal Cell / Q000175:diagnosis* / Q000556:secondary; D018293:Cystadenoma, Serous / Q000737:chemistry / Q000175:diagnosis / Q000209:etiology; D003593:Cytoplasm / Q000648:ultrastructure; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000556:secondary; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000032:analysis; D009378:Neoplasms, Multiple Primary / Q000737:chemistry / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000737:chemistry / Q000175:diagnosis* / Q000209:etiology; D012189:Retrospective Studies; D006623:von Hippel-Lindau Disease / Q000150:complications / Q000378:metabolism / Q000473:pathology*
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins